Stock listing
Nurix Therapeutics, Inc.
Selected listing: NRIX · NASDAQ · USD · US
Nurix Therapeutics, Inc. (NASDAQ:NRIX), Health Technology. Latest release Oct 5, 2026: Nurix Therapeutics Announces Second Research Term Extension…
- Ticker
- NASDAQ:NRIX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Nurix Therapeutics, Inc.
Nurix Therapeutics, Inc. (ticker: NRIX) is a public company based in the United States, focused on developing innovative therapies for cancer and other diseases. The company aims to create targeted treatments that harness the body's natural processes to combat diseases effectively.
Latest news from Nurix Therapeutics, Inc.
Nurix Therapeutics Announces Second Research Term Extension for Oncology Program Under Collaboration with Gilead Sciences
October 4, 2026
Nurix Therapeutics Announces Second Research Term Extension for Oncology Program Under Collaboration with Gilead Sciences
October 5, 2026
Nurix Therapeutics Announces Achievement of $7 Million Milestone Under Strategic Collaboration with Pfizer
September 28, 2026
Nurix Therapeutics Announces Achievement of $7 Million Milestone Under Strategic Collaboration with Pfizer
September 29, 2026
Nurix Therapeutics to Participate in Upcoming September Investor Conferences
September 1, 2026
Research Nurix Therapeutics, Inc.
Nurix Therapeutics, Inc. company profile
View the public company page for Nurix Therapeutics, Inc. on 6ix.
Nurix Therapeutics, Inc. news
Read company news and market updates connected to Nurix Therapeutics, Inc..
Nurix Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Nurix Therapeutics, Inc..